CNR résistance aux antibiotiques
Test analyse_sequence antibiogramme

Bienvenue sur le site du CNR de la Résistance aux Antibiotiques

Depuis le 01 janvier 2012, le CNR est coordonné par le Laboratoire de Bactériologie du Pr Plésiat (CHRU de Besançon).

Centre National de Référence
de la Résistance aux Antibiotiques

connexion au serveur résultats


Les Laboratoires

Accueil > Les Laboratoires > CHRU de Besançon > Publications de l’équipe

Les Laboratoires

Publications de l’équipe



> Resistance to polymyxins in Gram-negative organisms. Jeannot K, Bolard A, Plésiat P. Int J Antimicrob Agents. 2017 May;49(5):526-535.

> A case of multiple contamination with methylase ArmA-producing pathogens. Janvier F, Otto MP, Jové T, Mille A, Contargyris C, Meaudre E, Brisou P, Plésiat P, Jeannot K. J Antimicrob Chemother. 2017 Feb;72(2)

> First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. Al-Agamy MH, Jeannot K, El-Mahdy TS, Shibl AM, Kattan W, Plésiat P, Courvalin P. Microb Drug Resist. 2016 Nov 17.

> Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing. Cabot G, López-Causapé C, Ocampo-Sosa AA, Sommer LM, Domínguez MÁ, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Plesiat P, Oliver A. Antimicrob Agents Chemother. 2016 Nov 21;60(12)

> Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia. Al-Agamy MH, Jeannot K, El-Mahdy TS, Samaha HA, Shibl AM, Plésiat P, Courvalin P. Can J Infect Dis Med Microbiol. 2016

> Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins. Hocquet D, Petitjean M, Rohmer L, Valot B, Kulasekara HD, Bedel E, Bertrand X, Plésiat P, Köhler T, Pantel A, Jacobs MA, Hoffman LR, Miller SI. Environ Microbiol. 2016 Oct;18(10):3482-3493.

> Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa. Richardot C, Juarez P, Jeannot K, Patry I, Plésiat P, Llanes C. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2302-10

> Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia. Riou M, Avrain L, Carbonnelle S, El Garch F, Pirnay JP, De Vos D, Plésiat P, Tulkens PM, Van Bambeke F.Int J Antimicrob Agents. 2016 Jan;47(1):77-83

> Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae. Dortet L, Cuzon G, Plésiat P, Naas T. J Antimicrob Chemother. 2016 Jan;71(1):135-40.

> Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins. Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P. Antimicrob Agents Chemother. 2015 Oct;59(10):6248-55.

> The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Li XZ, Plésiat P, Nikaido H. Clin Microbiol Rev. 2015 Apr;28(2):337-418.

> Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD. Richardot C, Plésiat P, Fournier D, Monlezun L, Broutin I, Llanes C. Int J Antimicrob Agents. 2015 May;45(5):529-32.

> Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. Chalhoub H, Tunney M, Elborn JS, Vergison A, Denis O, Plésiat P, Kahl BC, Van Bambeke F, Tulkens PM. J Antimicrob Chemother. 2015 May;70(5):1596-8.

> Drug susceptibility testing by dilution methods. Jeannot K, Plésiat P. Methods Mol Biol. 2014;1149:49-58.

> Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospital. Molina L, Udaondo Z, Duque E, Fernández M, Molina-Santiago C, Roca A, Porcel M, de la Torre J, Segura A, Plesiat P, Jeannot K, Ramos JL. PLoS One. 2014 Jan 17;9(1):e81604.

> Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa. Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P. Antimicrob Agents Chemother. 2014;58(1):221-8

> A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa. Fournier D, Garnier P, Jeannot K, Mille A, Gomez AS, Plésiat P. J Clin Microbiol.

> Outbreak of metallo-β-lactamase VIM-2-positive strains of Pseudomonas aeruginosa in the Ivory Coast. Jeannot K, Guessennd N, Fournier D, Müller E, Gbonon V, Plésiat P. J Antimicrob Chemother. 2013 Jul 25.

> Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; GERPA Study Group. J Antimicrob Chemother. 2013 Aug;68(8):1763-71.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa. Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K. J Antimicrob Chemother. 2013 Aug;68(8):1772-80.

> Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plésiat P, Andremont A

> Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a. Jeannot K, Fournier D, Müller E, Cholley P, Plésiat P. J Clin Microbiol. 2013 Feb;51(2):673-5

> Spread of the bla(IMP-13) gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111. Fournier D, Jeannot K, Robert-Nicoud M, Muller E, Cholley P, van der Mee-Marquet N, Plésiat P. Int J Antimicrob Agents. 2012 Dec;40(6):571-3.

> IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa. Jeannot K, Poirel L, Robert-Nicoud M, Cholley P, Nordmann P, Plésiat P. Antimicrob Agents Chemother. 2012 Apr;56(4):2187-90.

> Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.Buyck JM, Guénard S, Plésiat P, Tulkens PM, Van Bambeke F. J Antimicrob Chemother. 2012 Mar;67(3):771-5.

bigbang communication Plan du site|Mentions légales|Rechercher|Liens